FULLER GILBERT A 4

What Happened

• Gilbert A. Fuller, a director of USANA Health Sciences (USNA), reported the conversion/exercise of 1,632 derivative awards on July 23, 2026. The filing shows 1,632 shares were acquired upon conversion and 1,632 shares were disposed at $0.00 (per the Form 4).
• This reflects a conversion/settlement of restricted stock units (RSUs) rather than an open-market purchase or cash sale. The filing does not show a cash value for the acquired shares.

Key Details

• Transaction date: July 23, 2026; Form 4 filed July 27, 2026 (appears to be filed after the typical 2-business-day window).
• Acquired: 1,632 shares via exercise/conversion of a derivative (transaction code M).
• Disposed: 1,632 shares at $0.00 (reported as disposed on the same date).
• Shares owned after transaction: Not specified in the filing.
• Footnotes: F1 — each restricted stock unit (RSU) equals a contingent right to one share. F2 — RSUs vest 25% on July 23, 2026, and on three later dates (Oct 22, 2026; Jan 21, 2027; Apr 22, 2027).

Context

• For retail investors: conversions of RSUs are routine compensation events. The immediate disposition at $0.00 commonly indicates a net settlement or shares withheld to satisfy tax obligations rather than a market sale, though the Form 4 itself does not state the reason.
• Because no open-market sale or purchase price is reported, this filing is primarily an administrative/compensation-related transaction and not necessarily a directional signal about the insider’s view of the stock.